Public disclosure of inside information according to article 17 MAR
Leverkusen, Germany (pta012/02.12.2021/08:50) - Biofrontera AG (ISIN: DE0006046113) (the "Company") has announced on November 10, 2021, that Prof. Dr. Lübbert has resigned from his position as member of the Management Board effective at the end of May 2022 and that a mutually agreed resignation before end of May 2022 was intended.
The Supervisory Board and Prof. Dr. Lübbert have agreed today that Prof. Dr. Lübbert will leave the Management Board of Biofrontera AG and the management of the German subsidiaries as of December 13, 2021. However, he will continue to serve as Executive Chairman of Biofrontera Inc.
The Supervisory Board is currently considering the future composition of the Management Board of Biofrontera AG.
emitter: Biofrontera AG
address: Hemmelrather Weg 201, 51377 Leverkusen
contact person: Investor Relations
phone: +49 (0) 214 87 63 20
ISIN(s): DE0006046113 (share)
stock exchanges: regulated market in Frankfurt, Dusseldorf; free market in Stuttgart, free market in Munich; open market in Berlin, Tradegate
other stock exchanges: Nasdaq